AstraZeneca Plc said on Monday U.S. regulators approved its diabetes drug Farxiga to be used as a treatment to reduce the chances of hospitalization for heart failure in adults with type-2 diabetes and other cardiovascular risks.
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: